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Summary Synthesis of pulmonary surfactant (PS) is necessary for normal functioning of the lungs and its
production is indicative of normal differentiated lung. The human alveolar carcinoma, A549, has been found
to synthesis and secrete PS in vitro. The purpose of this study was to optimise the culture conditions for PS
synthesis by A549 as well as to determine the potential role of foetal lung fibroblasts in the induction of PS by
glucocorticoids. A549 cells growing in filter wells produced higher levels of PS in response to steroid, a 5-fold
increase on the filter well compared to only a 1.5-fold increase when the cells were cultured on a conventional
plastic substrate. A549 cells grown in filter wells responded to coculture with fibroblasts whether in direct
contact or separated co-culture. A 20-fold increase in PS over control values was observed in separated
steroid-treated co-cultures, suggesting the presence of a diffusible factor. A partially purified factor was
isolated from fibroblast conditioned medium which was capable of inducing differentiation and other pheno-
typic changes in A549, namely induction of PS, reduction of plasminogen activator activity and reduction in
the in vivo growth of A549 xenografts in nude mice. These results suggest that, under the correct conditions,
A549 cells, although transformed, still retain the capacity to respond to differentiation-inducing signals from
normal fibroblasts.
As with many developing organ systems, organogenesis in
embryonic lung is strongly dependent on mutual interactions
between the epithelium and the mesenchyme (Taderera, 1967;
Wessels, 1977; Smith & Fletcher, 1979). While in some cases
the inductive capacity of the mesoderm may be constitutive,
in prostate and in lung at least part of the inductive capacity
of the mesoderm is induced by the systemic action of steroid
hormones (Cunha et al., 1983; Neubauer et al., 1983; Post et
al., 1984). In the perinatal maturation of the lung, glucocor-
ticoids do not act directly on the type II cells of the alveolar
epithelium, but indirectly via the lung mesenchyme (Post et
al., 1984). The production and presence ofpulmonary surfac-
tant (PS), a phospholipid-rich material which reduces surface
tension thereby preventing alveolar collapse during the expir-
atory phase (Goerke, 1974), is a major characteristic of lung
maturity and the principal differentiated function of type II
pneumocytes in the alveoli. Although PS production can be
induced by glucocorticoids directly (McLean et al., 1986), an
indirect action, mediated by lung fibroblasts, has been shown
to be the major perinatal inductive route (Post et al., 1984).
Binding of the glucocorticoid to fibroblastic receptors induces
the release of a factor, fibroblast pneumocyte factor (FPF),
which is the major inducer of synthesis of PS by type II cells.
There is evidence for both contact mediated and paracrine
control of differentiation, induced by cell-cell interaction.
While cell-cell contact or cell-matrix contact appears to be
important in differentiation of the enterocyte (Kedinger et al.,
1987) the effects seen in skin (Bohnert et al., 1986), lung
(Smith, 1979; Post et al., 1984) and some aspects of the
prostatic response (Djakiew et al., 1990) are mediated by
soluble factors.
Although the role of heterologous cell interaction in adult
tissues is less clearly established, adult urinary bladder
epithelium undergoes prostatic differentiation in response to
urogenital sinus mesenchyme (Cunha et al., 1983), and in
skin an epidermal-dermal interaction is required for complete
keratinisation and cross-linked envelope formation (Bohnert
et al., 1986). While a major breakdown of this type of
interaction would be expected in tumours, there is evidence
of some continuing interaction affecting both growth and
differentiation. Fibroblasts co-cultured with tumour cells
have been found to cause distinct degenerative changes in
KB (HeLa contaminated: ATCC Catalogue, Rockville, MD)
carcinoma cells (Imanishi et al., 1983) as well as growth
inhibition and differentiation in a human salivary carcinoma
(Shirasuna et al., 1988). Normal skin stroma can induce
basal cell carcinomas to express keratinisation (Boukamp et
al., 1985), and in vitro studies with NBT-II rat bladder
carcinoma cells in culture demonstrated that diffusible factors
produced by foetal urogenital sinus could influence the
phenotype of the carcinoma cells, characterised by an inhibi-
tion of cell proliferation, a stimulation of protein secretion
and an alteration in cell morphology (Rowley & Tindall,
1987). It has also been shown in embryo implantation studies
that interaction with the correct temporal phase at the cor-
rect site can inhibit the tumorigenic potential of melanoma
and neuroblastoma (Podesta et al., 1984).
The present report describes the role of fibroblasts in the
glucocorticoid-induced differentiation of the alveolar carcin-
oma cell line, A549 (Giard et al., 1972). It has been reported
previously that this cell line is a good potential model for the
study of alveolar maturation (Smith, 1977) and we show that,
in spite of its transformed phenotype, this tumour cell line
still responds to paracrine control of differentiation via a
soluble paracrine factor which can regulate tumour growth in
vivo.
Materials and methods
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Cells and culture
The human alveolar lung carcinoma cell line, A549, was
obtained from the American Type Culture Collection (CCL
185, ATCC, Rockville, MD). MOG-L-DAN (laboratory
identifiers, e.g. MOG, Medical Oncology Glasgow, will only
be used on first mention of a cell line), was derived in this
laboratory from a human mixed large cell and squamous
carcinoma from an adult male, SK-MES-1, a cell line from
human squamous carcinoma, was obtained from the ATCC
(HTB-58), WIL, a cell line derived from human adenocar-
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cinoma was obtained from the Haddow Laboratories, Sut-
ton, Surrey, NCI-H125, also from human adenocarcinoma,
was obtained from Dr D.N. Carney, Mater Misericordiae
Hospital, Dublin, and the human foetal lung fibroblast line,
MOG-LF113, was isolated in this laboratory from a first
trimester foetus and used between approximate generation
numbers 15-35. All lines were maintained in a 1:1 mixture of
Hams F1O:DMEM (NBL; Gibco) containing 2 mM glutamine
(Gibco) and supplemented with foetal bovine serum (FBS;
Biocon), the amount depending on the particular experiment.
All the cell lines used were shown to be free of mycoplasma
by monthly testing with the fluorescent DNA stain Hoescht
33258 (Chen, 1977).
Co-culture experiments
A549 were seeded at a density of 5 x 104 cells ml into either
6-well plates (Nunclon) or filter wells (Costar Transwells;
24.5 mm) fitted with a 10ltm thick polycarbonate membrane,
with a pore size of 0.4ltm, in complete medium. For direct
exposure to steroid, cultures were changed to serum-free
medium and 0.25jtM dexamethasone (DX; Merck, Sharp &
Dohme) added. For direct co-culture with fibroblasts, LF113
were grown to confluence in filter wells, 5 x I04 A549 cells
were seeded on top of the fibroblasts and the co-culture
incubated for a further 72 h in serum-free medium with or
without 0.25ALM DX.
In separated co-cultures, 1 x 106 LF113 fibroblasts were
seeded onto the bottom of the dish which housed the filter
well and A549 cells added to the filter well. Again, cultures
were incubated with or without 0.25fLM DX in serum-free
medium.
Measurement ofpulmonary surfactant
Pulmonary surfactant (PS) was measured using a modifica-
tion of the method of Smith (1977). Briefly, at the end of
each experimental procedure, A549 cells were labelled with
0.1ILCi ml-' (76 Ci mmol- ) of [methyl-3H]-choline (Amer-
sham) for 24 h at 37°C. The medium was removed and the
cells washed three times with serum-free medium. PS was
collected following incubation for 30 min with 3 ml of serum-
free medium containing 1.0 mM isoprenaline (Sigma), and
extracted in 9 ml of a 2:1 mixture of chloroform:methanol
(BDH). The upper aqueous layer was removed and the lower
layer dried in a vortex evaporator (Buchler). Disaturated
phosphatidylcholine (DPPC) was purified by alumina column
chromatography according to the method of Mason et al.
(1976). The samples were counted on a double channel scin-
tillation counter. Recovery was calculated by incorporating a
known amount of '4C-DPPC. Total cell-associated protein
was measured using the Bradford protein assay (Bradford,
1976; BioRad) and the PS produced was expressed per mg of
total protein.
In the direct co-culture experiments, a figure for the antici-
pated contribution of the fibroblasts to the protein content of
each culture was subtracted from the total protein per culture
before calculating the PS produced per mg protein. The
fibroblast protein figure was determined from identical filter
well cultures of the same numbers of fibroblasts grown with-
out A549 cells.
Preparation ofconditioned medium
LF113 cells were grown to confluence in either 175 cm2
flasks (Nunclon) or 850 cm2 roller bottles (Corning). At
confluence, the medium was changed and replaced with fresh
serum-free medium containing 0.25gM DX for 24 h. The
DX-containing medium was removed and the cells incubated
for 6 h. The medium was removed and the cells incubated for
a further 24 h in serum-free medium. This was collected,
centrifuged at 20,000g for 30 min and stored at -20°C until
required.
Ammonium sulphateprecipitation
Conditioned medium from steroid treated fibroblasts (CM),
or S-Sepharose eluate (see below), was cooled to 4°C, made
20%, 40%, 60% and 80% with ammonium sulphate, with
30 min on ice between each stage, centrifuged for 20 min at
20,000g, the precipitates dissolved in 2 ml PBSA (phosphate
buffered saline without Ca2l and Mg2+) and dialysed against
PBSA, at 4°C overnight.
Isoelectricfocusing
Conditioned medium was dialysed against tris-HCl, pH 7.4
buffer, mixed with 1% ampholyte solution (Biorad, pH range
3.0-10.0) and run on a Rotofor IEF apparatus (Biorad) for
4-6 h at 12w constant power until the voltage reached
plateau, when the samples were harvested simultaneously
under vacuum.
Ion exchange chromatography
A 8 x 25 cm glass column packed with 200 ml of S-Sepha-
rose (Pharmacia-LKB) was linked to a UV absorbance
monitor set at 280 nm (Uvicord; LKB) and a chart recorder.
The column was equilibrated with 50 mM 2-[N-morpholino]
ethane-sulphonic acid (MES), pH 6.0 at 4°C overnight. Ali-
quots from a 20 litre batch of conditioned medium were
diluted 1:4 with equilibration bufferjust prior to loading, and
the diluted medium allowed to run under gravity at 4°C for 4
days. The flow rate was between 10 and 20 ml min-'. At the
end of the run, proteins were eluted from the column using
1 M NaCl in 50 mM MES, pH 6.0. Fractions showing greatest
surfactant inducing activity were pooled and precipitated out
of solution with 60% (w/v) (NH4)2SO4, then lyophilised. This
was designated FDF and was used in all subsequent assays,
reconstituted in PBSA at 1.0ltgml-'.
Plasminogen activator activity
PA was assayed by a chromogenic assay using substrate
S-2251 (KabiVitrum) and 0.15 mg ml ' poly-D-lysine (Whur
et al., 1980).
Cloning experiments
Monolayer Cells were trypsinised, and diluted to 100 cells
ml-' in fresh culture medium, containing 10% FCS, and 5 ml
aliquots seeded into 6 cm petri dishes (Nunclon), which were
incubated for 10 days at 37°C to allow the formation of
colonies. Colonies were fixed for 10 min in methanol (BDH),
then air dried overnight, and stained with 0.1% crystal violet
(BDH). Colonies greater than 0.5 mm (approx. 500 cells)
were counted using an Artek colony counter.
Suspension A suspension of 103 cellsml1 in culture
medium, supplemented with 10% FBS, and containing 0.3%
agar (Gibco) was poured onto a preformed layer of 1% agar
in 35 mm petri dishes (Nunclon). Thereafter, the cells were
cultured for 14 days at 37°C in a humid 2% CO2 incubator.
Colonies were stained with 5 mgml1l 3-[4,5-dimethylthiazoyl
-2-yl]-2,5-diphenyl tetrazolium bromide (MTT; Sigma) for
4 h at 37°C in the dark. Colonies containing more than 20
cells were counted by eye using a binocular microscope.
Xenografts
Ten million A549 cells were injected into the flank of age-
matched MFI/NuNu/Ola/Hsd male nude mice, and allowed
to grow to approximately 0.5 g. The tumour was passaged in
2-3 mm cubes into more nude mice and allowed to grow to
approximately 0.5 g. Mice, bearing approximately size-
matched tumour, were then treated i.p. with either FDF,
50 ng g1 body weight, or PBSA placebo, for 12 out of 14
days. Tumour volume was assessed by double caliper
measurements according to Fergusson et al. (1986).PARACRINE CONTROL OF MALIGNANT LUNG EPITHELIUM 695
Statistics
Statistical analysis was by unpaired student's t-test.
Results
Pulmonary surfactant production
A549 cells were able to produce PS in culture, and this was
enhanced by DX in a dose dependent manner (Figure la)
reaching maximum stimulation at 0.1ILgml-' (0.25gM).
Four other cell lines, L-DAN, MES-1, WIL and H125, were
investigated to determine the specificity of the PS assay: PS
synthesis appeared to be specific to A549, since, with the
possible exception of L-DAN, none of the four other non-
small cell lung carcinomas studied produced PS in any appre-
ciable amounts (Table I). The amount produced in L-DAN
was not significantly different from the other lines.
DX was cytostatic at high cell density, reducing the satura-
tion density of A549 in a dose dependent manner (Figure
lb). This was confirmed in subsequent filter well cultures
where A549 cell protein per filter was consistently lower in
DX-treated cultures (data not shown).
A549 cells growing in filter wells produced 5-fold higher
levels of PS in response to steroid, compared to only a
1.5-fold increase when the cells were cultured on a conven-
tional plastic substrate (Table II).
Effect offibroblasts
A549 cells grown in filter wells responded to co-culture with
LF-113, whether in direct co-culture or separated co-culture,
by increasing the production of PS 5-fold (Table II). Treat-
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Table I Specificity of surfactant production and response to dexa-
methasone (DX)
3H-Choline inc., c.p.m./mgprotein
Cell line Control 0.25JLM DX
A549 2052-456 3606±220*
MOG-L-DAN 789± 17 1186± 124
SKMES-1 392±20 414±28
WIL 203±8 141±3
NCI-H125 138±6 90±11
*P<0.02
Table II Effect of filter well culture, dexamethasone, and fibroblast
co-culture on surfactant production
Fibroblasts
Combined (C)
Separate (S)
Filter (F) Conditioned Medium 3H-choline
Dish (D) DEX (toM) only (CM) inc mg-' protein
D 0 - 423± 54
D 0.25 - 614±48
F 0 - 625± 141
F 0.25 - 3251 ± 338a
F 0 C 4473± 1032
F 0.25 C 8657± 1216b
F 0 S 3208 358c
F 0.25 s 12358 1481d
F 0 CM 1990± 135
F 0.25* CM 4290± 342e
F
aP<0.001 against DX-free control on filter; bP< 0.02 against
DX-freecontrol on filter, combined with fibroblasts; cP<0.001 against
fibroblast-free control without DX; dp<0.001 against fibroblast-free
control with 0.25 laM DX; PJ<K0.001I against fibroblast-conditioned
medium without DEX pretreatment; *DX was removed 6 h before
conditioning commenced (see text).
ment of separated co-cultures with 0.25 ftM DX caused a
further 4-fold increase in the production of PS, so that the
total effect of fibroblasts plus steroid over the untreated filter
a ~ well culture of A549 alone was a 20-fold increase in PS
production.
A549 cells growing in direct contact with LFl 13 fibroblasts
did not show any increased activity in either fibroblastic or
steroid induction of PS relative to separated co-culture. The
fibroblast plus steroid effect was, if anything smaller. Data
are corrected for the presence of fibroblast protein (see
Materials and methods), but the precise contribution of
fibroblastic protein in direct co-culture is not known.
lo2 The activity of serum-free medium which had been condi- 101 102
tioned by fibroblasts (FCM), with or without pretreatment
.uAth n)Imox TV nY ., Aatarrsv"aA ^in AqA dv*oll-r%%., i WiLI V.L. - JAM llJ, was UVctelrinIeIU onI tJt7 ceiis grlWn in
filter wells. After 48h incubation, FCM from untreated
fibroblast gave higher levels of PS production than uncondi-
tioned medium, and this was increased further by pretreat-
ment of the fibroblasts with DX (Table II). These results
confirmed that LF113 cells released a soluble factor(s) which
could induce PS production in A549 cells, and that the
production of this factor could be enhanced by DX.
HPLC analysis ofglucocorticoid treated LF113 cells show-
ed a rapid fall in the glucocorticoid per cell and was unde-
tectable (<5 ng/106 cells) 2 h after steroid removal (data not
shown).
This suggests that glucocorticoid carry-over into condi-
tioned medium is negligible.
DX concentration [,uM]
Figure 1 Direct response of A549 to dexamethasone. a, Surfac-
tant production. Cells were grown to late log phase in 25 cm2
flasks, then treated with various concentrations of DX in serum-
free medium for 48 h. PS was determined as described in the
methods. b, Cytostasis. A549 cells, at approximately 5 x 104 cells
cm 2 in 25 cm2 flasks, were exposed to DX for 4 days, and
trypsinised and counted. Each data point represents the mean of
three observations ± s.e. of one representative experiment out of a
series of three.
Partialpurification ofMOG-LFJ13 conditioned medium
When ammonium sulphate precipitated fractions of FCM
were assayed for stimulation of PS synthesis, the highest
activity was observed in the 60% fraction (Figure 2a). Frac-
tionation of FCM on a Biorad preparative isoelectric focus-
ing gradient apparatus gave highest activity in fraction 12,
equivalent to pH 8.8 (Figure 2b). Cation-exchange chromato-
graphy followed by precipitation with 60% ammonium sul-
phate were therefore chosen for steps in partial purification.
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Figure 2 Fractionation of conditioned medium. a, Ammonium
sulphate precipitation. Conditioned medium was precipitated
with increasing concentrations of (NH4)2SO4, and filter well cul-
tures assayed with precipitates reconstituted in PBSA. 'S' is the
final supernatant after the final precipitation step. Each point is
the mean of four replicates. b, Isoelectric focussing. Conditioned
medium was fractionated on a Biorad Rotofor as described in the
Methods, and the fractions assayed in filter well cultures ofA549.
Each point is the mean of three replicates. c, The pH of the
gradient in b, is plotted in the bottom figure.
Dialysed conditioned medium from glucocorticoid-treated
fibroblasts was applied to S-Sepharose as described in the
Materials and methods and eluted with 1.0 M NaCl. The first
eight fractions, shown to contain the bulk of the activity
(data not shown) were pooled and the protein precipitated
with 60% (w/v) (NH4)2SO4. The resulting precipitate was
designated FDF. A dose response curve for induction of PS
with FDF is shown in Figure 3, showing that maximum
activity had still not been reached by 1 .tg ml-'.
Physico-chemical characterisation
Isoelectric focusing (see above and Figure 2) indicated a pK
of 8.8. Heating to 56'C for 30 min or 100'C for 5 min
destroyed about 20% of activity (Table III). Acidification to
pH 3.0 destroyed 90% of activity while increasing the pH to
9.0 had little effect. Digestion with 100 lg ml-' trypsin (Wor-
thington, recrystallised) or 100 pg ml-' pronase (Sigma, S.
griseus) removed 50% of the activity. This suggests that
v0.
0.0 0.2 0.4 0.6 0.8 1.0
FDF concentration (,ug m-'1)
Figure 3 Induction of surfactant production by FDF. FDF,
purified by S-Sepharose and ammonium sulphate precipitation as
described in the Methods, was added to confluent filter well
cultures of A549 and surfactant synthesis assayed after 3 days.
Each point is the mean and standard error of three replicates.
Table III Sensitivity of FDF to proteases, acid, alkali and heat
Temp % of
Treatment Concentration Time 'C control
Trypsin 100figml-' 2h 37 50
Trypsin + Soyabean inhib 1I00 tg ml ' 2h 37 90
100ILgml-'
Pronase l00lAgml- 2h 37 56
Heat 30 min 56 77
Heat 5 min 100 81
Acetic acid 1.OM I h 4 50
Tris HCI, pH9.0 0.5M I h 4 95
FDF is stable to heat and alkali but acid labile and protease
sensitive (Table III).
Activity ofother growthfactors
Eight other growth factors were assayed for surfactant induc-
tion at concentrations known to be active in other systems
(Table IV). Of these only PDGF, bFGF and IGF-I showed
significant activity, but much less than FDF. Although FDF
was present at 1.0 tg ml-' the bulk of this, as indicated by
preliminary SDS-PAGE analysis, is probably inactive, con-
taminating, high molecular weight proteins.
The apparent activity of insulin was not statistically signi-
ficant, and subsequent assays with insulin at a range of
concentrations from 0.1-10 igmlm' have not shown any
stimulation (data not shown).
Phenotypic effects ofFDF in vitro
Differentiation The data in Figure 3 indicate that FDF
induces surfactant synthesis in A549 cells. This has been
taken as evidence of differentiation.
Growth and survival Monolayer cloning was performed on
A549 cells which had been pre-treated with 0.1 ngml-10
tig ml FDF for 3 days. FDF had no effect on the clonogenic
potential of A549, with an average plating efficiency of 40%
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Table IV Effects of known growth factors on pulmonary surfactant
production in A549 cells
Growthfactor Mol. Wt. (kDa) Concentration % Stimulation
Control - - 0
TGF-a 5.6 0.1 AM 25
TGF-,B 25 1.0 ngml-' 4
PDGF 32 3.0uml-' 211**
(70,000 11 mg-)
bFGF 14-18 10.0 ngml-' 83*
IGF-1 7 10.Ongml-' 75*
Insulin 5.7 1.0 .tg ml- 138
EGF 6 0.1 M 31
Bombesin 1.6 0.1 JM 15
FDF ? 1.0tsgml- 1178***
*P<0.02; **P<0.01; ***P<0.002. Each observation represents
the mean ofthree separate experiments. Statistical analysis wascarried
out using the Student's t-test for paired samples.
(approximately 200 colonies per petri dish) in both control
and treated cultures. There was no difference in colony size
between treated and controls (data not shown).
A549 was able to grow well in semi-solid agar with a
plating efficiency of around 33%. Pre-treatment of A549 cells
in regular monolayer culture with FDF, 1.0pgml-1, caused
a significant reduction in colony formation in agar by appro-
ximately 30%.
Plasminogen activator (PA) PA activity was measured in
both A549 and another human lung adenocarcinoma, WIL.
Treatment of both cell lines with FDF caused a significant
reduction in PA activity (Table V).
Effect ofFDF on growth ofA549 cells as xenografts
FDF significantly inhibited the growth ofA549 as established
xenografts (Figure 4) and histology revealed extensive struc-
tural reorganisation in the treated tumour (Figure 5), with
stromal infiltration and signs of glandular-like or duct-like
formation not evident in controls. Observation of the gross
morphology of the tumours excised after treatment showed
not only a significant difference in size but also a marked
reduction in blood supply, judging by the whiter appearance
of the tumour.
Discussion
This study examined the role of fibroblasts, and a fibroblast-
derived factor, on the differentiation of A549 type II pneu-
mocyte tumour cells in vitro, and the effect of the factor on
growth in vivo. PS synthesis and, particularly, the response to
glucocorticoid, were greater when A549 cells were cultured
on a filter well membrane rather than on a conventional
plastic substrate, possibly due to the establishment of pola-
rity and/or higher oxygen tension, being nearer to the gas-
liquid interface. In epithelial cells, the expression of complete
differentiation requires the development of polarity within
the cell (Sattler et al., 1978; Chambard et al., 1982), although
to what extent polarity is achievable in transformed cells is as
yet unclear. It has been reported that for the correct expres-
sion of differentiated features in normal lung, it is often
necessary to have the cells growing close to the air-liquid
interface, since this mimics more closely the in vivo situation
(Van Scott et al., 1986), so elevating the culture closer to the
surface of the medium may have contributed to increased PS
synthesis.
The current data confirm that fibroblasts participate in the
response of alveolar type II epithelial cells to hydrocortisone,
and that the tumour cell line A549 retains this indirect
response to steroid. A549 cells do respond to steroid directly,
but to a much reduced extent. The addition of fibroblasts to
the dish underlying the A549 cells in the filter increased the
response of the A549 cells to DX nearly 4-fold over that of
A549 alone. This effect was not increased by direct contact
Table V Effect of FDF on suspension cloning and plasminogen
activator activity
Colony Change Change
Cell FDF number PE in PA Activit/a in
line ,Lgml-' (mean±s.e.) % PE (mean±s.e.) PA
A549 0 333 26 33 4.73±0.49
A549 1.0 221 16* 22 -33% 1.53±0.13* -68%
WIL 0 - 13.16±0.09
WIL 1.0 - - - 3.83± 0.21** -71%
*P<0.02; **P<0.002, unpaired student t-test; aActivity in ploug
units mg-' total cell protein. Abbreviations: FDF = fibroblast derived
factor; PE = plating efficiency; PA = plasminogen activator activity.
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Figure 4 Effect of FDF on growth of A549 as xenografts. Mice
received injections of FDF three times weekly, i.p., and the
tumour volumes were determined by double caliper measure-
ments at the times indicated. The difference at lld is significant
at P<0.0I (n= 5).
between the A549 cells and the fibroblasts, indicating that the
major effect was due to a paracrine factor as previously
described for normal developing lung (Smith, 1979). This was
confirmed by the activity of fibroblast-conditioned medium
which stimulated production of surfactant in A549 cells, and
the activity of which was also increased by glucocorticoid.
The activity of the fibroblasts in the absence of DX sug-
gests that they have constitutive synthesis and release a PS
stimulating factor(s) which may be increased by DX or dis-
tinct from the DX induced effect. Other growth factors
(PDGF, bFGF, and IGF-1) were shown to have some PS
inducing ability and may be released by fibroblasts without
steroid stimulation.
Although fibroblast conditioned medium was shown to be
active, a significant increase in this activity had been detected
in medium conditioned by glucocorticoid-treated lung fibro-
blasts. A simple purification procedure was undertaken in an
attempt to further enrich the activity of the conditioned
medium, and reduce the risk of steroid carry-over. However,
HPLC analysis indicated that steroid was undetectable
(<5 ng/106 cells) by 2 h after steroid removal, and condi-
tioning commenced at 6 h. As the cell concentration during
conditioning was approximately 2.0 x I05cellsml-', the
maximum possible concentration of steroid in conditioned
u
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Figure 5 Histology of xenografts. Tumours were excised 1
month post-implantation, after treatment for 12 days out of the
last 14 days with FDF, 50ngg-1, or PBS placebo, fixed and
stained with H&E as in the methods. a, control (75 x ); b, FDF
treated (75 x ); c, control (300 x ); d, FDF treated (300 x ).
medium would have been <1 ng ml' (2.5 x I0-9 M), pre-
viously found to be too low for induction of surfactant
synthesis. In view of this and subsequent purification steps, it
is unlikely that sufficient steroid remained to account for the
activity of the partially purified FDF.
These experiments indicate the presence of a diffusible
factor or factors, here called FDF, capable of stimulating PS
production in A549 alveolar carcinoma cells. The activity of
FDF was found to be heat and alkali stable but sensitive to
acid and protease. From the review of the activities of other
growth factors, the likeliest candidate would be PDGF.
However, PDGF is stable in acid and is therefore unlikely to
be the sole source of activity. Since bFGF and IGF-1 both
showed some activity, it is possible, particularly in view of
the heterogeneity of the material, that the total activity is due
to a synergistic interaction of two or more already estab-
lished growth factors. TGF-P was inactive and, in a recent
report (Torday & Kourembanas, 1990) has been shown to
antagonise the activity of FPF, the PS-inducing factor pre-
viously reported by Smith (1979). Further purification and
characterisation is clearly required before it can be estab-
lished that this is a new and unique factor.
Initial results from Smith (1979) suggested that the activity
described in normal developing lung was in a 5-7 Kd frac-
tion and was acid stable. Material from the present purifi-
cation was dialysed with a retention of approximately 10 Kd,
and was found to be acid labile, and may therefore be
distinct from Smith's FPF.
Proteolytic digestion with trypsin and pronase only reduc-
ed the activity by 50%. Since trypsin cleaves only on the
carboxyl side of lysine and arginine residues, it may still have
left active peptides, however, this is less likely with pronase,
and it is therefore possible that digestion was incomplete, or
some of the activity is not protein based.
The induction of surfactant synthesis in this system was
shown to involve the formation of characteristic multilamel-
lar bodies (data not shown) and is generally associated with
terminal differentiation of type II pneumocytes. Increased
clonogenicity in suspension (MacPherson & Montagnier,
1964) and elevated PA levels (Rifkind et al., 1974) have
generally been associated with the malignant phenotype,
although the expression of PA is by no means unique to
tumour cells (Duffy & O'Grady, 1984; Camiolo & Greco,
1986). The associated depression in suspension cloning and
PA, together with the induction of PS synthesis, suggest that
a general phenotypic change is occurring, with a coordinated
shift away from malignancy towards differentiation. The
possibility of such a relationship agrees with the findings of
Frame et al. (1984), who showed that in a panel of early
passage glioma cell lines, less well differentiated cell lines
expressed high PA levels, while a decrease in PA expression
was observed in cells induced to differentiate with glucocor-
ticoid and glia maturation factor.
FDF reduced clonogenicity in soft agar by about 30%
without any effects in monolayer, suggesting specific inhibi-
tion of anchorage independent growth. This is in agreement
with the observations of Shirasuna et al. (1988), who noticed
a marked reduction, not only in colony number, but also in
colony size when a salivary adenocarcinoma cell line was
treated with WI-38 conditioned medium.
As the factor represses tumour growth in vivo, this also
substantiates the observation that induced differentiation re-
presses malignancy. This may occur by increased sensitivity
to density limitation of growth and the withdrawal of termin-
ally differentiated cells from the proliferative pool. Further-
more, since the tumour seemed to be less well vascularised,
induction of differentiation may have led to a reduction in
angiogenesis factors produced by the tumours.
The inhibition of PA activity produced by the WIL cell
line, derived from an adenocarcinoma, suggests that FDF
activity may not be restricted to alveolar carcinoma, and
preliminary data from treatment of other tumours in vivo, as
yet with very small numbers of animals, suggests that FDF
may have activity with other non-small cell lung cancers and
small cell lung cancer, but not with ovarian carcinoma.PARACRINE CONTROL OF MALIGNANT LUNG EPITHELIUM 699
In summary these results provide good evidence that foetal
lung stromal cells have important paracrine effects on malig-
nant lung epithelium. This is due, at least in part, to a
diffusible factor, which can be isolated, and the existence of
which may point to a possible mode of antitumour therapy
which should have minimal peripheral toxicity. Analogous
activity has been observed in prostate where fibroblasts can
influence the secretory capacity of prostatic carcinoma in a
paracrine manner (Djaklew et al., 1990) and the appearance
of columnar cells in prostatic carcinoma can be induced by
genital tract mesoderm (Hayashi et al., 1990), suggesting that
this type of paracrine control may be widespread and poten-
tially applicable to other types of carcinomas.
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